Stem cells are the most vital cells found in both humans and non-human animals. These cells are also considered to be the heart of regenerative medicine. The regenerative drugs have ability to grow new cells followed by replacing the damaged and dead cells. It also has the ability to replicate & repair and further replace the other damaged tissues in the human body. In addition, the stem cell-based therapies are used in the treatment of various chronic diseases such as cancer and blood disorders. The increase in prevalence of chronic diseases has contributed to the growth of the stem cell therapy market. Moreover, the long working hours, restricted or less physical activity, and unhealthy eating & the drinking habits further contributing to the prevalence of chronic diseases in humans and led to rise in need for stem cell based therapies.
Referring to the study, Global Stem Cell Therapy Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027. Some of the key companies operating in the global stem cell therapy market include JCR Pharmaceutical, Chiesi Pharmaceuticals, Osiris Therapeutics, Anterogen, Takeda (TiGenix), NuVasive, Medi-post, Molmed, Pharmicell and among others.
Based on types, Global stem cell therapy market can be segmented as Allogeneic and Autologous. Allogeneic stem cell therapy holds major share in global market owing to rise in prevalence of cancer and related diseases among people. In addition, based on applications, market can be segmented as cornea, wounds & injuries, cardiovascular diseases, musculoskeletal disorder and others.
Request For Sample Report-https://kenresearch.com/sample-report.php?Frmdetails=NDQ0NzAy
Increase in GMP-certification approvals for cell therapy production facilities, followed by growth in availability of funding for stem cell research, rise in advent of advanced genomic procedures used in stem cell analysis, increase in funds in the development of new stem lines, greater emphasis on human embryonic stem cells and increase in clinical trials for stem cell based-therapies are some major factors, which are responsible for growth of the stem cell therapy market. Apart from this, high cost of cell-based research and ethical concerns related to embryonic stem cells may impact the market. Moreover, rise in demand for cell & gene therapies and emergence of iPSCs as an alternative to ESCs are leading opportunities for global market.
Based on regional analysis, the North-America is a leading region in global stem cell therapy market owing to increase in number of clinical trials, extensive research & development, presence of key players engaged in developing stem cell therapies and rise in public awareness related to the therapeutic potency of stem cells in disease therapy across the region. The Asia-Pacific and Europe regions are estimated to witness higher growth rate due to large patient population, establishment of several stem cell banks, and increase in government support by providing funds and strong product pipelines in regenerative therapies during the forecast period. It is projected that future of the global stem cell therapy market will be bright on account of rise in prevalence of chronic diseases and growth in development of stem cell-based therapies during the forecast period.
For More Information, refer to below link:-
Global Stem Cell Therapy Market Research Report
Related Reports
Follow Us
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
